Scientist Solutions: International Life Science Community By Scientists For Scientists
Home » Societies » The Biotech Research Society of India Forum

The Biotech Research Society of India Forum

Thanks to our sponsors who make this site possible
Welcome Members and guests. Our Forum is brought to you through our partnership with Scientist Solu- which manages these pages to promote the free exchange of useful scientific information. We
encourage you to dive in and join the conversation!

How do I use this forum?
Registered members can create new topics and reply to topics from other users. To learn more about s-
uccessful posting in the forums Click Here. Subscribing to Society Sub-forums will keep you informed
and involved.
Disclaimer - The The Biotech Research Society of India Society supports the free exchange of scientific information, but is not responsible or liable for comments made in public forums such as this one. Topics and posts deemed unsuitable will be moderated and removed.

The Biotech Research Society of India Subforums

RSS Feed
Sub-forumsTopics  Replies  ViewsLast Post

Strategies to Identify Drug Targets/Biomarkers

22 23 36089

Urgent Dilution problem! Please hel ...

by Saluferkimo
May 21, 2015, 15:24 PM

Target Validation Techniques

Target Validation Techniques
9 9 24594


by skarthikumar
Nov 09, 2012, 11:02 AM


Extent and rate of absorption, distribution, metabolism and excretion ( ADME)
18 46 53389


by Debbie Reed Bietz
Jun 25, 2012, 11:25 AM

Bioprocessing/Scale Up and Isolation

Fermentation, cell culture, expression, and recovery
22 27 37589

isolating dna from spotted on filte ...

by Pippuri
May 04, 2015, 16:26 PM

Good Manufacturing/Validation Practice (GMP/GVP)

Control and management
24 51 51904

Performance Qualification (PQ) of L ...

by Eibhor
Aug 17, 2015, 21:01 PM


Pharmacology equipment
18 49 47299

How to choose your system Fiber opt ...

by Idealphotonics
Oct 05, 2015, 6:41 AM

Assay Development & Protocols

Also, remember to visit the protocols tab on the homepage toolbar
48 46 59929

Xanthine Oxidase Inhibitory Assay

by Paye
Feb 27, 2012, 20:34 PM

Society Overview

The aims & objectives of the Biotech Research Society [BRSI] are:
  • To promote the R&D in biotechnology in India
  • To bring interaction between the academic institutes and the biotech industries, interact with the industries and help them in resolving their problems, as well make them aware with the latest developments in the biotech sector
  • To provide and arrange the training in biotechnology, dissemination of biotech knowledge through the organization of the lectures, seminars and symposia on the scientific programmes and societal missions.

Contact Society Forum Organizer
Society Organizer: Ashok Pandey

Click here to
Become a member & join our
community (It's easy & free)
Already a member? Please log in
User Name  
Forget Password?
News Feeds from
BioTech News
Biotech news continually updated from thousands of sources around the net.

Bristol-Myers Squibb achieves encouraging data in small cell lung cancer patients with both Opdivo alone and in combination with Yervoy Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. News: On Monday, Exelixis with its partner Ipsen announced that its phase 3 trial, known as CELESTIAL, met its primary endpoint of overall survival .

Th... )--Regulatory News: Pershing Square Holdings, Ltd. today announces that it has purchased, through PSH's agent, Jefferies International Limited ,... )--Today from APICS 2017, the premier event for supply chain, logistics and operations management professionals, the supply chain association, APICS, announced the launch... )--IGeneX Inc., a CLIA and New York-approved Reference Laboratory, specializing in testing for tick-borne diseases, is pleased to announce the launch of three new t... )--A.M. Best has released enhancements to the BestLink online platform to fully integrate recent Best's Credit Rating Methodology updates into Best's Insurance Reports... IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Navient Corporation and Encourages Investors with Losses to Contact the Firm )--Lundin Law PC, a shareholder rights firm, announces the ... (more)

Novartis, a global health care company based in Switzerland, is closing its Sandoz division in Broomfield at 2555 W. Midway Blvd. The site is a manufacturing facility for generic drugs. Approximately 450 jobs will be affected as a result of the closure, Novartis spokeswoman Sofina Mirza-Reid said this morning.

Women who have had gestational diabetes may be able to reduce or even eliminate their risk for heart problems by eating better, exercising more and adopting other healthy habits in the years after giving birth, according to a study by researchers at the National Institutes of Health.

's stock had its "buy" rating reissued by stock analysts at Cowen and Company in a research report issued to clients and investors on Thursday. They currently have a $135.00 target price on the medical research company's stock.

According to Zacks, "Endo's top line should continue to benefit from robust performance of Xiaflex and sterile injectables. Endo has centralized and streamlined its supply chain, quality and compliance organization in order to create a more cohesive and efficient structure.

According to Zacks, "Shares of Discovery Communications have underperformed its industry on a year-to-date basis. In fact, the company has been struggling with declining advertisement revenues for quite some time.

Shares of Merck KGaA have received an average rating of "Hold" from the twenty-four ratings firms that are covering the stock, MarketBeat reports. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company.

Northern Trust Corp grew its holdings in Neogen Corporation by 2.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 530,832 shares of the company's stock after purchasing an additional 14,353 shares during the quarter.

AC Immune SA and Alnylam Pharmaceuticals are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. AC Immune SA presently has a consensus price target of $21.67, suggesting a potential upside of 86.62%.

Complete the form below to receive the latest headlines and analysts' recommendationsfor Quidel Corporation with our free daily email newsletter: from a hold rating to a buy rating in a report issued on Friday. The brokerage currently has $50.00 target price on the stock.

Seattle Genetics, Inc. insider Clay B. Siegall sold 18,832 shares of the business's stock in a transaction dated Wednesday, October 11th. The shares were sold at an average price of $61.18, for a total value of $1,152,141.76.

Johnson & Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients aged 12 and over with moderate to severe cases of the unsightly skin condition. The logo of healthcare company Johnson & Johnson is seen in front of an office building in Zug, Switzerland July 20, 2016.

Q: I'm 55 and just rolled an old 401 over into an IRA. What are some stock investments you would suggest for me? As you get older, your investing priorities change.

According to biotech lore, the Bt pesticides introduced into many GMO food crops are natural proteins whose toxic activity extends only to narrow groups of insect species . Therefore, says the industry, these pesticides can all be safely eaten, e.g. by humans.

England's chief medical officer has warned of a "post-antibiotic apocalypse" as she issued a call to action urging global leaders to address the growing threat of antibiotic resistance. Without the drugs used to fight infections, common medical interventions such as caesarean sections, cancer treatments and hip replacements would become incredibly "risky", she said.

German pharmaceutical giant Bayer AG has reached a 5.9 billion euro deal to sell parts of its Crop Science unit to German chemical company BASF to alleviate regulatory concerns over its planned takeover of U.S. seed and weed-killer company Monsanto Co. Monsanto last year accepted an offer from Bayer to pay $57 billion to its shareholders and assume $9 billion in debt.Bayer said Friday it's working with authorities with the aim of closing the deal by early 2018.

Thank You to Our Sponsor